Carmel Diagnostics

Carmel Diagnostics is a pioneering force in Medical Equipment Manufacturing, dedicated to revolutionizing IVF success rates through cutting-edge technology. Carmel Diagnostics’ commitment to innovation is exemplified by the Fertissimo TCL Analyzer, a groundbreaking non-invasive embryo selection system. This system is designed to enhance embryo viability assessment, improve IVF success rates by up to 20%, and reduce the risk of multiple births.

With successful clinical trials already performed in Israel and Europe (Spain), Carmel Diagnostics is poised to launch a new generation of its product, undergoing extensive clinical validation. The business model is based on a pay-per-test system using disposables and software control, ensuring accessibility for clinics worldwide. Carmel Diagnostics is dedicated to providing accurate, scientifically-based solutions to address critical needs in the IVF process. The device can also be used for additional applications such as: Risk stratification for Heart Failure patients, Diagnosis and treatment monitoring of AMD, early diagnosis of Parkinson and Alzheimer's, assessment of damage in TBI - Traumatic Brain injury. We base our solution on using oxidative stress as a novel efficient biomarker.

Carmel Diagnostics continues to push the boundaries of medical diagnostics. The primary address is Qiryat Tiv‘on, IL. Carmel Diagnostics' mission is to improve patient outcomes and transform healthcare practices globally. We invite the company’s manager to create a customized and exclusive company showcase and product listing on our platform to further highlight Carmel Diagnostics' innovative solutions and reach a broader audience.